Search results for "Lymphoblast"

showing 10 items of 107 documents

Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group

2021

Haematologica : journal of the European Hematology Association 106(5), 1390-1400 (2021). doi:10.3324/haematol.2019.244780

Oncologymedicine.medical_specialtyArticle03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansCumulative incidence030304 developmental biology0303 health sciencesChildhood Cancer RegistryUnivariate analysisbusiness.industryIncidenceLymphoma Non-HodgkinMyelodysplastic syndromesIncidence (epidemiology)Lymphoblastic lymphomaMyeloid leukemiaNeoplasms Second PrimaryHematologyPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseLymphoma030220 oncology & carcinogenesisFemaleCranial Irradiationbusiness
researchProduct

Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts.

2010

Background Although multimodality treatment can induce high rate of remission in many subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with incurable disease. The effect of human bone marrow (BM) mesenchymal stem cells (MSC) on tumor cell growth is controversial, and no specific information is available on the effect of BM-MSC on NHL. Methodology/Principal Findings The effect of BM-MSC was analyzed in two in vivo models of disseminated non-Hodgkin's lymphomas with an indolent (EBV− Burkitt-type BJAB, median survival = 46 days) and an aggressive (EBV+ B lymphoblastoid SKW6.4, median survival = 27 days) behavior in nude-SCID mice. Intra-peritoneal (i.p.) i…

Pathologymedicine.medical_specialtyStromal cellTransplantation HeterologousMice Nudelcsh:Medicinemesenchimal stem cellsMice SCIDMiceimmune system diseaseshemic and lymphatic diseasesmesenchymal stem cells non-Hodgkin's lymphoma.AnimalsHumansMedicinehuman lymphoma xenograft; mesenchimal stem cellsOncology/Hematological Malignancieslcsh:ScienceSCID MiceMultidisciplinaryHematology/Bone Marrow and Stem Cell Transplantationbusiness.industryLymphoma Non-HodgkinLymphoblastlcsh:RMesenchymal stem cellNon-Hodgkin's LymphomaMesenchymal Stem CellsHematopoietic Stem Cellsmedicine.diseaseCoculture TechniquesLymphomaNon-Hodgkin's lymphomaEndothelial stem cellTransplantationApoptosislcsh:QHematology/Lymphomas and Chronic Lymphoblastic LeukemiabusinessMesenchymal Stem Cells; SCID Mice; Non-Hodgkin's LymphomaResearch Articlehuman lymphoma xenograft
researchProduct

Patient with Kabuki syndrome and acute leukemia

2003

Kabuki syndrome is a multiple congenital anomaly/mental retardation syndrome which often involves recurrent infections. There is cumulative evidence of an immunodeficiency in Kabuki patients. We report a 2-year-old girl with typical Kabuki syndrome, who developed acute lymphocytic leukemia. The patient showed low levels of immunoglobulins G and A and a history of recurrent infections, that might indicate an immunodeficiency leading to an increased susceptibility to cancer. The girl was treated according to BFM protocols adapted to the patient's impaired cardiac situation and severe underweight. She achieved continual complete remission. Classical and molecular cytogenetic analyzes did not d…

Pediatricsmedicine.medical_specialtyAcute leukemiabusiness.industryKabukiInfantCancerPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseIntellectual DisabilityImmunopathologyAcute lymphocytic leukemiaImmunologymedicineHumansAbnormalities MultipleFemaleAbnormalitybusinessKabuki syndromeGenetics (clinical)ImmunodeficiencyAmerican Journal of Medical Genetics
researchProduct

Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells

2015

Abstract Ethnopharmacological relevance Rosmarinic acid (RA), a major hydrosoluble bioactive compound found in the Chinese medicinal herb, Salvia miltiorrhiza Bunge, which has been used in traditional Chinese medicine to treat various diseases, including cancer. However, the mechanisms have not been fully elucidated. Aim of the study Guided by microarray hybridization and Ingenuity Pathway Analysis, we identified modes of action of rosmarinic acid (RA) isolated from S. miltiorrhiza on acute lymphoblastic leukemia cells. Materials and methods Microarray data were verified by independent methods: Real-time RT-PCR (mRNA expression), resazurin assay (cytotoxicity of RA towards parental CCRF-CEM…

Programmed cell deathCell SurvivalDNA damageNecroptosisCellAntineoplastic AgentsApoptosisSalvia miltiorrhizaPharmacologyCell morphologyDepsidesSalvia miltiorrhizaCell Line TumorDrug DiscoveryCell AdhesionmedicineHumansLymphocytesCells CulturedMembrane Potential MitochondrialPharmacologybusiness.industryGene Expression ProfilingCell CycleNF-kappa BPrecursor Cell Lymphoblastic Leukemia-LymphomaCell cycleMolecular biologyDrug Resistance MultipleMolecular Docking Simulationmedicine.anatomical_structureCinnamatesDrug Resistance NeoplasmApoptosisComet AssayReactive Oxygen SpeciesbusinessDNA DamageJournal of Ethnopharmacology
researchProduct

Classification of Congeneric and QSAR of Homologous Antileukemic S–Alkylcysteine Ketones

2021

Based on a set of six vector properties, the partial correlation diagram is calculated for a set of 28 S-alkylcysteine diazomethyl- and chloromethyl-ketone derivatives. Those with the greatest antileukemic activity in the same class correspond to high partial correlations. A periodic classification is performed based on information entropy. The first four characteristics denote the group, and the last two indicate the period. Compounds in the same period and, especially, group present similar properties. The most active substances are situated at the bottom right. Nine classes are distinguished. The principal component analysis of the homologous compounds shows five subclasses included in t…

Quantitative structure–activity relationshipLogarithmStereochemistryprincipal component analysisLymphoblastic LeukemiaPharmaceutical Science01 natural sciencesAnalytical Chemistrylcsh:QD241-44103 medical and health sciences0302 clinical medicinelcsh:Organic chemistryGroup (periodic table)Drug DiscoveryPhysical and Theoretical ChemistryPartial correlationperiodic classificationChemistrypartial correlation diagramOrganic ChemistryDiagraminformation entropy0104 chemical sciences010404 medicinal & biomolecular chemistryChemistry (miscellaneous)030220 oncology & carcinogenesisPrincipal component analysisLipinski's rule of fiveMolecular MedicineMolecules
researchProduct

Non-response bias as a likely cause of the association between young maternal age at the time of delivery and the risk of cancer in the offspring.

2003

Some epidemiological studies have shown an association between young maternal age at the time of delivery and risk of cancer in the offspring. In a recent German case-control study, there was a twofold increase in the leukaemia risk for children whose mothers were aged < 20 years at the time of delivery. As the prevalence of younger mothers among control families was particularly low, data on maternal age distributions for the general population of Germany were obtained in order to examine the representativeness of the control sample. Despite the excellent sampling frame based on data from complete and up-to-date population registries and a satisfactory response rate among controls ( approx…

RiskPediatricsmedicine.medical_specialtyEpidemiologyOffspringPopulationCentral Nervous System NeoplasmsNeuroblastomaBiasEpidemiologyMedicineHumansNon-response biaseducationSampling frameResponse rate (survey)education.field_of_studybusiness.industryLymphoma Non-HodgkinCase-control studyInfant NewbornPrecursor Cell Lymphoblastic Leukemia-LymphomaSample size determinationCase-Control StudiesSample SizePediatrics Perinatology and Child HealthFemalebusinessDemographyMaternal AgePaediatric and perinatal epidemiology
researchProduct

Association between Serum Heat Shock Proteins and Gamma-Delta T Cells—An Outdated Clue or a New Direction in Searching for an Anticancer Strategy? A …

2021

HSPs demonstrate a strong association with gamma-delta (γδ) T cells. Most of the studies regarding interactions between the parameters were conducted in the 1990s. Despite promising results, the concept of targeting γδ T cells by HSPs seems to be a forgotten direction due to potent non-peptidic phosphoantigens rather than HSPs have been found to be the essential stimulatory components for human γδ cells. Currently, with greater knowledge of lymphocyte diversity, and more accurate diagnostic methods, we decided to study the correlation once again in the neoplastic condition. Twenty-one children with newly diagnosed acute lymphoblastic leukaemia (ALL) were enrolled on the study. Serum HSP90 c…

Technologyacute lymphoblastic leukaemiaQH301-705.5LymphocyteCD3QC1-999Human leukocyte antigenBiologyFlow cytometryHeat shock proteinmedicineGeneral Materials ScienceBiology (General)InstrumentationChildhood allQD1-999Fluid Flow and Transfer Processesmedicine.diagnostic_testAcute lymphoblastic leukaemia Gamma-delta T cells Serum HSP90Process Chemistry and Technologyserum HSP90TPhysicsGeneral Engineeringgamma-delta T cellsEngineering (General). Civil engineering (General)Hsp90Computer Science ApplicationsChemistrymedicine.anatomical_structureImmunologybiology.proteinTA1-2040CD8Applied Sciences
researchProduct

A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes

1996

The human tyrosinase gene has been reported previously to code for two distinct antigens recognized on HLA-A2 melanoma cells by autologous cytolytic T lymphocytes (CTL). By stimulating lymphocytes of melanoma patient MZ2 with a subclone of the tumor cell line of this patient, we obtained a CTL clone that lysed this subclone but did not lyse other subcloncs of the Same melanoma cell line. The sensitive melanoma subclone was found to express a much higher level of tyrosinase than the others, suggesting that the antigen recognized bv the CTL might be encoded by tyrosinase. Transfection of a tyrosinase cDNA demonstrated that the CTL clone indeed recognized a tyrosinase product presented by HLA-…

TyrosinaseMolecular Sequence DataImmunologyClone (cell biology)BiologyHLA-B44 AntigenAntigenAntigens NeoplasmTumor Cells CulturedmedicineHumansImmunology and AllergyAmino Acid SequenceMelanomaAntigen PresentationBase SequenceMonophenol MonooxygenaseLymphoblastMelanomaTransfectionmedicine.diseaseMolecular biologyCTL*CytolysisHLA-B AntigensOligopeptidesT-Lymphocytes CytotoxicEuropean Journal of Immunology
researchProduct

PETECHIAL BRAIN HAEMORRHAGES IN ACUTE LYMPHOBLASTIC LEUKAEMIA.

2013

A 37-year-old office worker was referred to our hospital with severe weakness, malaise, headache and altered mental status. He was mildly febrile (37.5°C) with reported episodes of agitation. A blood count revealed 709 720 white blood cells (WBC) / μl with 33 000 platelets/μl. The clinical, imaging and laboratory workup led to a diagnosis of acute lymphoblastic leukaemia (ALL) …

Weaknessmedicine.medical_specialtyHematologybusiness.industryLymphoblastic leukemia brain haemorrhagesNeurooncologyBlood countGastroenterologyOffice workersSurgeryMalaisePsychiatry and Mental healthhemic and lymphatic diseasesInternal medicineMedicineLymphoblastic leukaemiaSurgeryPlateletNeurology (clinical)medicine.symptombusiness
researchProduct

Acetylcysteine therapy for chronic hepatitis C: are its effects synergistic with interferon alpha? A pilot study.

2008

This trial reports the 6-month results of a pilot study using lymphoblastoid interferon alpha (IFNalpha) and acetylcysteine (N-acetylcysteine) separately and in combination in patients with chronic hepatitis C, genotype 1b, who were nonresponders to previous treatment with recombinant IFNalpha alone.21 patients were randomly divided into three groups of seven each. Group A was treated with lymphoblastoid IFNalpha 6MU three times a week for 6 months; group B received the same schedule of lymphoblastoid IFNalpha as group A plus acetylcysteine 1200 mg/day per os in two administrations, and group C received only acetylcysteine 1200 mg/day per os in two administrations.Mean serum alanine aminotr…

business.industryAlpha interferonAlpha (ethology)General MedicinePharmacologyVirologylaw.inventionAcetylcysteinePharmacotherapyGenotype 1bChronic hepatitislawRecombinant DNAMedicinePharmacology (medical)Lymphoblastoid Interferonbusinessmedicine.drugClinical drug investigation
researchProduct